GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Vivozon Pharmaceutical Co Ltd (XKRX:082800) » Definitions » Cyclically Adjusted Revenue per Share

Vivozon Pharmaceutical Co (XKRX:082800) Cyclically Adjusted Revenue per Share : ₩6,934.59 (As of Mar. 2024)


View and export this data going back to 2005. Start your Free Trial

What is Vivozon Pharmaceutical Co Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Vivozon Pharmaceutical Co's adjusted revenue per share for the three months ended in Mar. 2024 was ₩420.569. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ₩6,934.59 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Vivozon Pharmaceutical Co's average Cyclically Adjusted Revenue Growth Rate was -24.50% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was -11.60% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was -7.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Vivozon Pharmaceutical Co was -3.20% per year. The lowest was -11.60% per year. And the median was -6.40% per year.

As of today (2024-06-05), Vivozon Pharmaceutical Co's current stock price is ₩3415.00. Vivozon Pharmaceutical Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was ₩6,934.59. Vivozon Pharmaceutical Co's Cyclically Adjusted PS Ratio of today is 0.49.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Vivozon Pharmaceutical Co was 1.31. The lowest was 0.23. And the median was 0.55.


Vivozon Pharmaceutical Co Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Vivozon Pharmaceutical Co's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vivozon Pharmaceutical Co Cyclically Adjusted Revenue per Share Chart

Vivozon Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11,402.50 10,791.60 10,571.60 9,220.18 7,449.03

Vivozon Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9,179.99 8,657.91 8,240.03 7,449.03 6,934.59

Competitive Comparison of Vivozon Pharmaceutical Co's Cyclically Adjusted Revenue per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Vivozon Pharmaceutical Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vivozon Pharmaceutical Co's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Vivozon Pharmaceutical Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Vivozon Pharmaceutical Co's Cyclically Adjusted PS Ratio falls into.



Vivozon Pharmaceutical Co Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Vivozon Pharmaceutical Co's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=420.569/118.8477*118.8477
=420.569

Current CPI (Mar. 2024) = 118.8477.

Vivozon Pharmaceutical Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 4,783.580 99.353 5,722.197
201409 3,617.849 99.608 4,316.652
201412 2,418.065 99.098 2,899.972
201503 2,313.998 99.720 2,757.855
201506 3,656.015 100.050 4,342.918
201509 2,761.671 100.110 3,278.576
201512 3,061.365 100.220 3,630.375
201603 2,693.727 100.560 3,183.604
201606 2,349.379 100.790 2,770.298
201609 2,071.944 101.460 2,427.023
201612 2,206.643 101.560 2,582.261
201703 1,858.755 102.850 2,147.873
201706 1,987.018 102.610 2,301.457
201709 2,115.617 103.490 2,429.570
201712 1,279.768 102.990 1,476.818
201803 1,435.205 104.100 1,638.528
201806 1,542.263 104.130 1,760.246
201809 1,179.412 105.650 1,326.743
201812 903.999 104.350 1,029.595
201903 706.029 104.490 803.043
201906 4,703.931 104.880 5,330.391
201909 699.287 105.200 790.006
201912 520.968 105.120 589.002
202003 359.085 105.540 404.363
202006 453.593 104.870 514.051
202009 316.875 106.200 354.613
202012 563.139 105.765 632.795
202103 467.447 107.357 517.478
202106 399.780 107.579 441.658
202109 424.626 108.759 464.014
202112 467.379 109.676 506.462
202203 505.249 111.806 537.071
202206 222.053 114.083 231.327
202209 299.909 114.831 310.399
202212 323.962 115.200 334.219
202303 2,878.617 116.550 2,935.377
202306 344.386 117.140 349.407
202309 380.726 119.111 379.884
202312 477.236 118.848 477.236
202403 420.569 118.848 420.569

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Vivozon Pharmaceutical Co  (XKRX:082800) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Vivozon Pharmaceutical Co's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=3415.00/6934.59
=0.49

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Vivozon Pharmaceutical Co was 1.31. The lowest was 0.23. And the median was 0.55.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Vivozon Pharmaceutical Co Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Vivozon Pharmaceutical Co's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Vivozon Pharmaceutical Co (XKRX:082800) Business Description

Traded in Other Exchanges
N/A
Address
Yongin Techno Valley, 9th and 10th Floor, Building D, Guseong-ro 357, Giheung-gu, Gyeonggi-do, Yongin-si, KOR
Vivozon Pharmaceutical Co Ltd is a global innovative drug development company.

Vivozon Pharmaceutical Co (XKRX:082800) Headlines

No Headlines